GLPBio

Validamycin A

Catalog No.: GC45135Purity:>60.00%Synonyms: Validacin
Validamycin A, ein Fungizid, ist ein landwirtschaftliches Antibiotikum.

Die Produkte sind ausschließlich für Forschungszwecke bestimmt. Nicht zur Anwendung am Menschen. Wir verkaufen nicht an Patienten.


Validamycin A
Cas No.: 37248-47-8
10mM (in 1mL Water)In Stock
$50.00
1
100mgIn Stock
$45.00
1

Zitate (Citations)

Für dieses Produkt sind derzeit keine Zitate verfügbar. Nachfolgend finden Sie ausgewählte Publikationen, die GlpBio-Produkte zitieren.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Beschreibung (Description)

Validamycin A is an agricultural antibiotic fungicide that protects crops from the fungus Rhizoctonia solani by inhibiting trehalase, with an IC50 value of 72μM[1]. Validamycin A also inhibits the growth of Aspergillus flavus (MIC value: 1μg/mL) and is commonly used for controlling diseases such as rice sheath blight and potato black scurf, as well as for studying trehalase activity and trehalose synthesis in biological systems[2,3,4,5].

In vitro, Validamycin A (0.125-1μg/mL), either alone or in combination with amphotericin B (2μg/mL), treatment of human bronchial epithelial cells (BEAS-2B) for 24h did not induce significant cytotoxicity. Validamycin A (1μg/mL) treatment of the Aspergillus flavus ATCC 204304 strain for 24h significantly reduced the adhesion capacity of A. flavus[1]. Validamycin A (1μM) treatment of Rhizoctonia cerealis shake-flask cultures for 8 days significantly reduced the total inositol content in the mycelium (by 62%) and decreased the levels of free and hydrolyzed inositol in the culture supernatant[6].

In vivo, exposure of approximately 100 Aedes aegypti mosquito eggs to rearing medium containing Validamycin A (0.1, 0.2, 0.5mg/mL) in a 200 mL volume, with larvae continuously exposed until the adult stage, significantly delayed hatching, pupation, and eclosion processes, and dose-dependently inhibited the flight ability of adults (100% of adults were unable to fly at the 0.5mg/mL concentration)[7]. Validamycin A (150, 300, 600, 1200mg/kg) co-administered orally with pentylenetetrazol (PTZ) to adult zebrafish, followed by 20min of electroencephalogram (EEG) recording, dose-dependently reduced the number and cumulative duration of PTZ-induced seizure-like EEG activities[8].

References:
[1] PLABOUTONG N, EKRONARONGCHAI S, NIWETBOWORNCHAI N, et al. The inhibitory effect of validamycin A on Aspergillus flavus[J]. International Journal of Microbiology, 2020, 2020(1): 3972415.
[2] ASANO N, YAMAGUCHI T, KAMEDA Y, et al. Effect of validamycins on glycohydrolases of Rhizoctonia solani[J]. The Journal of Antibiotics, 1987, 40(4): 526-532.
[3] GARCÍA M D, ARGÜELLES J C. Trehalase inhibition by validamycin A may be a promising target to design new fungicides and insecticides[J]. Pest Management Science, 2021, 77(9): 3832-3835.
[4] HU F, SU W, LI C, et al. Control Efficacy of Validamycin A (0.2 Billion Spores/ml) Paenibacillus polymyxaDN-1 3% AS for Rice Sheath Blight[J]. Agricultural Science & Technology, 2016, 17(11): 2615.
[5] MATSUURA K. Characteristics of validamycin A in controlling Rhizoctonia diseases[M]//Natural Products. Pergamon, 1983: 301-308.
[6] ROBSON G D, KUHN P J, TRINCI A P J. Effect of validamycin A on the inositol content and branching of Rhizoctonia cerealisand other fungi[J]. Journal of General Microbiology, 1989, 135(4): 739-750.
[7] MARTEN A D, STOTHARD A I, KALERA K, et al. Validamycin A delays development and prevents flight in Aedes aegypti(Diptera: Culicidae)[J]. Journal of Medical Entomology, 2020, 57(4): 1096-1103.
[8] LEE E, BANIK A, LEE K B, et al. Assessment of the novel anti-seizure potential of validamycin A using zebrafish epilepsy model[J]. Molecules, 2024, 29(11): 2572.

Protokoll (Protocol)

Cell experiment [1]:

Cell lines

BEAS-2B cells (human bronchial epithelial cells)

Preparation Method

BEAS-2B cells were treated with Validamycin A (0.125, 0.5, 1μg/mL) alone or in combination with amphotericin B (2μg/mL) for 24h. The toxicity of Validamycin A and amphotericin B on BEAS-2B cells using Lactate Dehydrogenase (LDH) Cytotoxicity Colorimetric Assay Kit II. After 24h, LDH reaction mixture was added (25μL) and incubated at 37℃ for 30min. Then, ODs were measured at 450nm using a spectrophotometer.

Reaction Conditions

0.125, 0.5, 1μg/mL; 24h

Applications

Treatment with Validamycin A (0.125-1μg/mL) alone or in combination with amphotericin B (2μg/mL) did not produce significant toxicity to BEAS-2B cells.

Animal experiment [2]:

Animal models

Adult zebrafish

Preparation Method

Validamycin A (150, 300, 600, 1200mg/kg) was administered along with PTZ into the mouth of adult zebrafish, and EEG activity in the brain was monitored using noninvasive flat electrodes and perfomed for 20min.

Dosage form

150, 300, 600, 1200mg/kg; p.o.

Applications

Treatment with Validamycin A can reduce the number and cumulative duration of PTZ-induced seizure-like EEG activity.

References:
[1] PLABOUTONG N, EKRONARONGCHAI S, NIWETBOWORNCHAI N, et al. The inhibitory effect of validamycin A on Aspergillus flavus[J]. International Journal of Microbiology, 2020, 2020(1): 3972415.
[2] LEE E, BANIK A, LEE K B, et al. Assessment of the novel anti-seizure potential of validamycin A using zebrafish epilepsy model[J]. Molecules, 2024, 29(11): 2572.

Produktdokumente (Product Documents)

Purity:>60.00%Appearance:A solid

Chemische Eigenschaften (Chemical Properties)

CAS-Nr.
37248-47-8
Synonyme
Validacin
SMILES
O[C@H]([C@H]1O)[C@H](O)[C@@H](CO)O[C@@]1([H])O[C@H]2[C@H](O)[C@@H](O)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@@H]2CO
Summenformel
C20H35NO13
Molekulargewicht
497.5
Löslichkeit
DMSO: 2 mg/ml,PBS (pH 7.2): 10 mg/ml
Lagerung
4°C, protect from light, stored under nitrogen
Allgemeine Hinweise
Wählen Sie anhand der Löslichkeitsdaten des Produkts ein geeignetes Lösungsmittel. Aliquotieren Sie die Stammlösung nach der Herstellung, um wiederholte Gefrier-Auftau-Zyklen zu vermeiden.
Verwenden Sie Stammlösungen bei Lagerung bei -80°C innerhalb von 6 Monaten bzw. bei -20°C innerhalb von 1 Monat.
Zur Verbesserung der Löslichkeit das Röhrchen auf 37°C erwärmen und für eine angemessene Dauer beschallen.
Versandbedingungen
Evaluierungsmuster werden mit Kühlakkus versandt. Andere verfügbare Größen werden bei Raumtemperatur oder auf Anfrage mit Kühlakkus versandt.

Rechner (Calculators)Molarität / Verdünnung / Molekulargewicht / Einheitenumrechnung / In-vivo-Formulierung / Löslichkeit

g/mol

Reviews

Review for Validamycin A

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%